Wauwatosa-based CyteGen has raised another $1.1 million to fund their research into extending human life and reversing age-related decline. A Jan. 13 SEC filing shows the company raised the $1.1 million in equity through three investors. This is their second funding round. The company also raised $1 million back in April of 2018.

CyteGen Corp. was co-founded in 2015 by Nuray George Ugras and is based in the UWM Innovation accelerator at 1225 Discovery Parkway in Wauwatosa. The company is focused on mitochondrial dysfunction’s link to aging and neurodegenerative disorders such as Parkinson’s and Alzheimer’s.

CyteGen’s team includes experts and researchers from the Medical College of Wisconsin, the University of Wisconsin-Madison, Johns Hopkins University, the University of California-San Francisco Parnassus Campus, biopharma company GlaxoSmithKline, MIT and more.

Click here to read the full article.